Brief: Episurf Medical Says Receives FDA 510(K) Clearance For Episealer® Patellofemoral System
24/12/2022 08:01
Dec 24 (Reuters) - Episurf Medical AB EPISb.ST :
* EPISURF MEDICAL RECEIVES FDA 510(K) CLEARANCE FOR
EPISEALER®
PATELLOFEMORAL SYSTEM
* EPISURF MEDICAL - EPISURF MEDICAL WILL NOW PREPARE FOR
MARKET
LAUNCH OF COMPANY'S FIRST PRODUCT ON US MARKET.
Source text for Eikon: ID:nWkr8mRxBq
Further company coverage: EPISb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Episurf Medical AB
See all newsBrief: Futur Pension Holding Increases Stake In Episurf Medical
Brief: Episurf Board To Propose Transaction Approval
Brief: Mofast Divests Major Shareholding In Episurf, To Increase Holding
Brief: Episurf Medical Enters Into LoI Regarding Acquisition Of Property
Brief: Episurf Medical Signs Property Management Agreement With Newsec